baber/WOPTO huggingface dataset:
Patent JP-2814609-B2 (JP)
IPC: C08J9/12
Filed: 1989-09-22
Granted: 1998-10-27
Abstract: In accordance with the present invention, there is provided a bubble-containing ethylene/ alpha -olefin rubber excellent in kneadability, characterized in that the ethylene/ alpha -olefin rubber prepared by copolymerization of 50 - 95 mol% of ethylene, 5 - 50 mol% of  alpha -olefin having at least 3 carbon atoms and 0 - 10 mol% of non-conjugated polyene contains 5 - -1000 parts by volume, based on 100 parts by volume of said rubber, of bubbles and has a water absorption volume as measured in accordance with ASTM D 1506 of less than 20% by volume of the total bubble volume.
Patent JP-3388152-B2 (JP)
IPC: B05D7/24
Filed: 1997-09-22
Granted: 2003-03-17
Abstract: PROBLEM TO BE SOLVED: To improve accuracy in amount of applied adhesive. SOLUTION: In a method, an adhesive apply condition is made normal, by throwing away the remaining adhesive with high speed at a top part of a nozzle in a take-out step 110. A trail of application is carried out by ejecting out the adhesive from the nozzle in a trial application step 111. The amount of applied adhesive in the trial step is measured in a measuring step 112. When the trial of application resulted in success, the adhesive is applied to all the adhesive applying region of a body to be bonded in an adhesive application step 114.
Patent JP-3223332-B2 (JP)
IPC: G04B27/04
Filed: 1992-09-08
Granted: 2001-10-29
Abstract: This unidirectional correction arrangement (1) for a display device exhibiting a circular element (2) provided with teeth (3) includes a cylindrical element (4) around which is wrapped a helical spring (5), one of the ends of which serves as a finger (6) adapted to come into contact with a tooth (3). When the cylindrical element (4) is driven in rotation in a sense (A) for which the force (F1) exerted on the finger by the tooth is directed in a sense tending to wrap the spring around the cylindrical element and to tighten it therearound, the circular element (2) rotates. Such circular element (2) will not be driven when the cylindrical element (4) is driven so as to rotate in a sense (B) for which the force (F2) exerted on the finger by the tooth is directed in a sense tending to open the helical spring.
Patent JP-3499932-B2 (JP)
IPC: C08F8/08
Filed: 1994-11-07
Granted: 2004-02-23
Abstract: A radial or star asymmetric block copolymer of the formula (I) is new. (A-HD)x-Y-(UD)z (I). A = vinyl aromatic hydrocarbon block having a peak Mw of 4000-20000; HD = hydrogenated conjugated diene block having a peak Mw of 10000-100000; Y = multifunctional coupling agent; UD = unhydrogenated conjugated diene block having a peak Mw of 1000-80000; x = 2-20; z = 1-10; and x+z = 3-30. The block copolymer has a vinyl aromatic hydrocarbon content of 4-35 wt.%. Also claimed are (i) an adhesive or sealant compsn. comprising the copolymer and a tackifying resin; and (ii) compsns. which are crosslinked.
Patent JP-3862456-B2 (JP)
IPC: B60W30/02
Filed: 1999-09-28
Granted: 2006-12-27
Abstract: An apparatus for controlling behavior of a vehicle has an ECU (2) which estimates behavior of a yaw rate of the vehicle using a first target yaw rate, a second target yaw rate and an actual yaw rate to control the behavior of the yaw rate. The ECU (2) completes the behavior control if a completion condition is achieved during over-steering control of the vehicle. <IMAGE>
Patent JP-2612175-B2 (JP)
IPC: A61K31/505
Filed: 1987-11-05
Granted: 1997-05-21
Abstract: This invention relates to the synergistic enhancement of certain antihypertensives by the conjunctive use of certain cardiotonic agents. More specifically, this invention relates to the enhancement of the blood pressure lowering effect achieved with alpha1-adrenoceptor antagonists by the conjunctive administration of cardiotonic agents possessing the ability to specifically inhibit cyclic AMP-phosphodiesterase.
Patent JP-H066157-B2 (JP)
IPC: A61M5/00
Filed: 1991-11-01
Abstract: A device is provided for indicating when an intravenous needle has entered the vein through the use of a solid fiber optic (20) mounted in the needle (14) for showing visual instantaneous vein entry. The distal end (22) of the fiber optic (20) is polished to be flush with the distal point (16) of the needle. The fiber optic (20) is sized to have an outer diameter which will extend through the cannula of the needle. This polished distal end (22) reflects color, such as red blood, immediately upon vein entry and exposure to blood to the magnifying system (30,36) forming a part of the invention at the rear or proximal end of the fiber optic (20). The user observes immediate vein entry without any blood flow or exposure to blood. Other embodiments utilize the fiber optic (20) as the needle (14), thus eliminating the needle itself. <IMAGE>
Patent JP-3057213-B2 (JP)
IPC: B29C65/18
Filed: 1991-10-08
Granted: 2000-06-26
Abstract: A device (10, 50) for collecting particles, such as human cells, from a fluid sample, and for transferring the collected particles to a receiver, such as a glass microscope slide, provides substantially exact replication of the spatial distribution of the cells on the collection device. The device supports a surface-trapping filter (12, 54) on a tubular rim (16, 60), with a precise degree of flatness, and fastens the filter in place at a mounting shoulder (18, 62) recessed below the rim. Distortions of the mounting shoulder or of the filter at the mounting shoulder, caused by securing the filter to the shoulder, are confined to the shoulder structure, and do not detract from the desired precision flatness of the filter and rim structure. <IMAGE>
Patent JP-2655733-B2 (JP)
IPC: H01H33/91
Filed: 1989-12-28
Granted: 1997-09-24
Abstract: High and medium voltage gas-blast circuit-breaker comprising a pressurised dielectric gas-filled cylindrical insulating surround, a main stationary contact (2), a stationary arc contact (3) and a movable gadget connected to an operating member comprising a main moving contact (5A), a moving arc contact (4A) and a blast cylinder (5) associated with a blast nozzle (6) and co-operating with a first piston (13), a second piston (14) integral with the movable gadget and sliding in a second stationary cylinder (8B), characterised in that the second piston (14) has a large cross-section in relation to the cross-section of the blast cylinder, the said second piston being associated with means (15) of low charge loss communication with the arc zone, the said second piston being drilled with calibrated orifices (14C) in order to limit the pressure on that face of the said piston receiving the gases heated by the arc. 
<??>Applications to high and medium voltage circuit-breakers. 
<IMAGE>
Patent JP-3153212-B2 (JP)
IPC: A61P25/28
Filed: 1999-12-13
Granted: 2001-04-03
Abstract: This invention relates to the isochroman compound of formula (I) <CHEM> and its pharmaceutically acceptable salts, which are useful as an amyloid aggregation inhibitor and for treating Alzheimer's disease. This invention also relates to processes for producing the isochroman compound, which comprises cultivating Penicillium simplicissimum FERM BP-6357 and then isolating the isochroman compound from the fermentation broth. The present invention also relates to a pharmaceutical composition comprising the isochroman compound.
Patent JP-3767290-B2 (JP)
IPC: B65H16/02
Filed: 1999-12-15
Granted: 2006-04-19
Abstract: A miniaturized rolled-paper holding mechanism (10) which is capable of detecting the residual quantity of rolled-paper in both horizontally and vertically installed states of a printer. The rolled-paper holding mechanism (10) includes a rolled-paper holder (21), a holder cover (41), a positioning member (51), and a residual-paper-quantity sensor (61). The positioning member (51) is structured such that, as the holder cover (41) is opened or closed, the inclination angle of the positioning member (51) is varied with respect to a second-bottom-portion inclined surface (29) formed in the rolled-paper holder (21). Further, a second positioning groove (31) -which, when the holder cover (41) is closed, can be contacted with rolled-paper R having a given diameter- is formed between the positioning member (51) and the second-bottom-portion inclined surface (29) of the rolled-paper holder (21). <IMAGE>
Patent JP-3318869-B2 (JP)
IPC: A01N59/00
Filed: 1991-12-27
Granted: 2002-08-26
Abstract: Stable agrochemical compositions are provided by incorporating at least one of the  alpha  -unsaturated amine derivatives having the following formula: <CHEM> wherein one of X<1> and X<2> is an electron attracting group and the other is hydrogen or an electron attracting group; R<1> is a group attached through a nitrogen atom; R<2> is hydrogen or a group attached through a carbon, nitrogen, or oxygen atom; n is an integer of 0, 1, or 2; and A is a substituted or unsubstituted heterocyclic group or a substituted or unsubstituted cyclic hydrocarbon group; and salts thereof, into an agrochemically acceptable solid carrier (clay minerals capable of adsorption (including fuller's earth, terra alba, bentonite, and activated fuller's earth), zeolite, activated charcoal, and  beta  -cyclodextrin, etc.) under a pH 5.5 or less condition. The agrochemical (pesticidal) compositions exert potent shelf life and light-resistance.
Patent JP-4225572-B2 (JP)
IPC: C07F9/59
Filed: 1997-06-20
Granted: 2009-02-18
Abstract: The invention relates to a new pyridyl alkene and pyridyl alkine acid amides according to the general formula (I) as well as methods for their production, medicaments containing these compounds as well as their medical use, especially in the treatment of tumors or for immunosuppression.
Patent JP-3005046-B2 (JP)
IPC: C12Q1/68
Filed: 1991-01-18
Granted: 2000-01-31
Abstract: PCT No. PCT/NL91/00009 Sec. 371 Date Jul. 16, 1992 Sec. 102(e) Date Jul. 16, 1992 PCT Filed Jan. 18, 1991 PCT Pub. No. WO91/10675 PCT Pub. Date Jul. 25, 1991.The invention relates to primers and a method of detecting human papilloma virus (HPV) genotypes by means of the Polymerase Chain Reaction (PCR). The invention provides such primers and such PCR conditions that in principle any genital HPV genotype is detected. The general primers according to the invention consist of an oligonucleotide which comprises at the 3' end one of the sequences of SEQ ID NO: 3-6, or a sequence which is homologous to one of these four sequences as to at least 75%. In order to obtain amplification even in the case of a limited number of mismatches, in the PCR a relatively low annealing temperature of 30 DEG -50 DEG  C. and a relatively high Mg+2 concentration of 2-10 mM are used. The invention enables a sensitive and reliable preselection of samples to be examined, such as cervical smears.
Patent JP-2764903-B2 (JP)
IPC: H01P1/213
Filed: 1987-05-27
Granted: 1998-06-11
Abstract: A dielectric block filter (501) which may be mounted on a printed circuit board or other substrate as a single component. The dielectric filter utilizes metallized hole foreshortened resonators (529-535) in the dielectric block (501), which employs capacitive coupling between resonators controlled in part by an electrode strip (553-558) coupled to the conductive material covering the majority of the dielectric block (501) surface. Input and output coupling is accomplished via terminals (505-507) asymmetrically arranged in a mounting bracket (503). Mounting tabs (515-523) on the bracket (503) opposite a recessed area holding the dielectric block secure the filter (501) to the circuit board and provide ground connection for the filter. Two or more filters (501) may be arranged on the circuit board to form a duplexer.
Patent JP-3226924-B2 (JP)
IPC: F26B11/12
Filed: 1993-07-21
Granted: 2001-11-12
Abstract: PCT No. PCT/GB93/01535 Sec. 371 Date Jan. 23, 1995 Sec. 102(e) Date Jan. 23, 1995 PCT Filed Jul. 21, 1993 PCT Pub. No. WO94/02241 PCT Pub. Date Feb. 3, 1994An apparatus enabling reaction and post-reaction processing in a single assembly including a reaction chamber and a filtration and/or drying chamber adjacent to one another, the chambers being selectively isolated or in communication. A shaft common to both chambers is capable of rotation and axial movement. An agitator arm is fitted to the shaft in the reaction chamber while a smoothing and pressing arm is fitted to the shaft in the filtration and/or drying chamber. The chambers may be formed in a single cylindrical vessel with an intermediate cross wall providing isolation between the chambers. A U-shaped conduit extends between the chambers and by-passes the cross wall to enable communication between the chambers. The conduit may incorporate a valve/pump to facilitate transfer between the chambers. The shaft is journalled through the cross wall and has a bellows apparatus to protect the bearing from the respective chambers.
Patent JP-H0761079-B2 (JP)
IPC: H04L29/08
Filed: 1991-01-11
Abstract: A network control system for use in a communication network controls the receipt and transmission of messages between at least a pair of nodes of the network. Messages conveyed within the network include short messages having a length less than a predetermined number of bytes and long messages having a length greater than the predetermined number of bytes. The network control system is located at least at one of the nodes and includes a connectionless network control portion for controlling the transmission and receipt of the short messages and a connection-oriented network control portion coupled to the connectionless network control portion for establishing a connection with the other node for controlling the transmission and receipt of the long messages between the pair of nodes. The connectionless portion of the system includes a transport stage which provides end-to-end reliability within the system, a network stage for establishing routing of the messages, and a data link stage for providing point-to-point reliability and other control functions such as message flow control, node resynchronization, and node suspension. The connection-oriented portion of the system includes a session stage for handling the communication of long messages greater then the predetermined number of bytes in length.
Patent JP-3534749-B2 (JP)
IPC: A61K35/76
Filed: 1992-08-20
Granted: 2004-06-07
Abstract: The present invention relates, in general, to an adenovirus mediated transfer of genes to the gastrointestinal tract. In particular, the present invention relates to a method of recombinant, replication-deficient adenovirus mediated transfer of therapeutic genes to the gastrointestinal tract whereby therapeutic proteins for systemic and/or local purposes are produced.
Patent JP-3407885-B2 (JP)
IPC: C07K1/113
Filed: 1992-02-26
Granted: 2003-05-19
Abstract: A process for phosphorylating a peptide comprises reacting an aqueous solution of the peptide with an effective amount of phosphorous oxychloride under conditions favoring phosphorylation of the peptide. In a specific embodiment, the peptide is insulin. A phosphorylated insulin is used in the treatment of diabetes mellitus wherein the phosphorylated insulin is produced or purified with an effective amount of phosphorus oxychloride to have substantially reduced iso-electric points and to have the property of reducing hyperglycemia without substantially inducing hypoglycemia. In a specific embodiment of the invention, the method comprises administering to a human being an effective therapeutic amount of a phosphorylated insulin essentially free of unmodified insulin and having substantially reduced iso-electric points whereby hyperglycemia is reduced substantially without inducing hypoglycemia. A phosphorylated insulin having either at least one phosphate group substituted on serine residues in the insulin or at least one phosphate group substituted on threonine residues in the insulin is for use in the treatment of diabetes mellitus.
Patent JP-3254564-B2 (JP)
IPC: D03D11/02
Filed: 1992-09-11
Granted: 2002-02-12
Abstract: The object of the invention is a method for manufacturing a laminating reinforced fibre structure (1), in which fibre layers (7, 8) made of cross-woven warp or weft yarn bundles are manufactured as a warp structure, these being tied together with ties (9) and a filler (4) is placed in the channel formed by the layers one top of each other and the ties. In accordance with the invention two fiber layers (7, 8) one top of one another are woven together in a manner that is as such known, in such a way that the warp (2) or alternatively weft (3) bundles of yarns run in turn in the upper and lower structures thus forming large channels in relation to the size of the fabric and pieces impermeable to a binder substance is used as a filler (4).
Patent JP-3667345-B2 (JP)
IPC: C07F9/38
Filed: 1996-06-27
Granted: 2005-07-06
Abstract: PCT No. PCT/GB96/01548 Sec. 371 Date Jan. 8, 1998 Sec. 102(e) Date Jan. 8, 1998 PCT Filed Jun. 27, 1996 PCT Pub. No. WO97/05149 PCT Pub. Date Feb. 13, 1997A process for removing N-(phosphonomethylglycine) (glyphosate) or a salt or ionic form thereof from an aqueous mixture in which it is present, wherein the aqueous mixture is an effluent from a glyphosate manufacturing process, the process comprising adding to the mixture of ions capable of forming an insoluble or partially soluble complex glyphosate salt, and removing the complex salt from the mixture. An additional process permits recovery of glyphosate from the precipitate of complex salts by a process comprising forming an aqueous slurry of the precipitate having a pH greater than 8 and removing the resultant metal oxide from the slurry to give an aqueous solution containing glyphosate.
Patent JP-4424761-B2 (JP)
IPC: C12N5/10
Filed: 1998-07-01
Granted: 2010-03-03
Abstract: Transcriptional activators which differ in their activation potential by more than 3 orders of magnitude are provided. The transactivators are fusions between a DNA binding protein (e.g., a Tet repressor) and minimal transcriptional activation domains derived from Herpes simplex virus protein 16 (VP16). Substitution mutations at amino acid position 442 within the minimal VP16 domain provide transactivators with differing transactivation ability. Moreover, chimeric activation domains comprising both wild type and mutant minimal VP16 domains provide additional variants with differing transactivation ability. Various aspects of the invention pertain to nucleic acid molecules, vectors, host cells, fusion proteins, transgenic and homologous recombinant organisms and methods of regulating gene transcription.
Patent JP-2882679-B2 (JP)
IPC: A61K38/31
Filed: 1990-04-23
Granted: 1999-04-12
Abstract: Linear octapeptides which are somatastatin analogues have the formula: <CHEM> wherein A<1> to A<8> may represent Ala, pyridyl-Ala, Leu, Ile, Val, Phe, Nle, Trp, beta-Nal, ortho- and para-substutited Phe, 2,4-dichloro Phe, pentafluoro-Phe, Ser-R<4> or Thr-R<4>; R<1> and R<2> independently represents H, lower acyl or lower alkyl; R<3> represents H, -NH2 or lower alkyl; R<4> represents nothing, a glycosyl residue or a carbohydrate. Also disclosed are pharmaceutical compositions containing the octapeptides, for inhibiting release of growth hormone, IGF-1, insulin and glucagon. A process for the preparation of the octapeptides is described.
Patent JP-2872406-B2 (JP)
IPC: G01F15/18
Filed: 1992-05-04
Granted: 1999-03-17
Abstract: PCT No. PCT/EP92/00965 Sec. 371 Date Mar. 21, 1994 Sec. 102(e) Date Mar. 21, 1994 PCT Filed May 4, 1992 PCT Pub. No. WO92/21005 PCT Pub. Date Nov. 26, 1992.A float type flowmeter including a bottom flow-through fitting and an upper flow-through fitting in spaced relationship with the bottom flow-through fitting; and an exchangeable measuring tube extending between the fittings. Each fitting has an opening formed as a cylindrical recess in alignment with each other with the openings each receiving a respective opposite end of the measuring tube. An external guide on each end of the measuring tube is in close fit with respectively an adjacent cylindrical recess, thereby facilitating axial movability of the measuring tube within predetermined limits in the longitudinal direction of the measuring tube. A distributor head having mutually communicating axial and radial ducts is located in the upper flow-through fitting closely above the upper end of the measuring tube; and a sealing closure screw operative in conjunction with an axial stop is provided for limiting the vertical axial movement of the measuring tube between the fittings.
Patent JP-H0751645-B2 (JP)
IPC: C08L67/00
Filed: 1991-06-13
Abstract: Novel compositions of phosphoroustriscaprolactams, including tris(caprolactyl)phosphite which may be produced in accordance with the methods disclosed, finding particular utility as catalysts for esterification and other condensation reactions.
Patent JP-3044573-B2 (JP)
IPC: F24H9/12
Filed: 1991-07-10
Granted: 2000-05-22
Abstract: A combined control and regulating valve (1) having a housing (2) with an inlet (3) and an outlet (4) as well as a partition (5) between said inlet and outlet and having a seat (6) designed for an interaction with a main valve body (7), which is adjustable from outside. To said inlet and said outlet are connected a measuring nipple each (50 and 74, respectively) via a bore (30, 31 and 40, 41 respectively) for the measurement and the control of temperature and/or pressure. One of the measuring nipples is designed as a multiple function nipple (50) having a cut-off-valve permitting tapping and filling of the medium, which is to be controlled/regulated. In order to enhance reliability in operation, to provide even more precise and reliable measuring results, to reduce the risk of clogging of the cavities leading to the measuring nipples, to reduce costs for manufacturing and/or fitting, to provide preconditions for various conditions of operation and for partial changes as well as for being able to affect other valve properties, like sealing properties and use of differently designed or dimensioned valve bodies, at least one bore (30, 31) is extended axially to communicate with a so extended portion (110) with a zone of the medium channel (73) downstream of said seat (6) via an area immediately above said valve body (7) or around said seat (6) by means of a casing provided with a groove.
Patent JP-3302358-B2 (JP)
IPC: C07K14/47
Filed: 1990-10-12
Granted: 2002-07-15
Abstract: Conventionally, animal tissue from one species can only be transplanted into another species when the species are concordant; otherwise, hyperimmune rejection ensues. In this invention, donor tissue is modified, for example by being transgenic, to express or otherwise be in association with one or more substances, referred to as homologous complement restriction factors (HCRFs), which are active in the recipient species to prevent the complete activation of complement and therefore rejection. The invention is in part based on the discovery that the alternative pathway of complement activation, rather than the classical pathway, is responsible for hyperacute discordant xenograft rejection.
Patent JP-4083804-B2 (JP)
IPC: A61B19/08
Filed: 1996-10-11
Granted: 2008-04-30
Abstract: The present invention relates to blankets for use with forced air convection systems, wherein the blankets allow for access to portions of a patient's body before, during or after surgery. In addition, the blankets according to the present invention allow versatility in use by providing access to portions of the patient's body before, during, or after surgery, but which may also completely cover the patient after the surgical procedure is complete. To accomplish these purposes, the blankets according to the present invention include seals or separation lines which extend into the interior of the blanket and which may be separated to allow access to portions of the patient's body.